BAX
NYSEBAXTER INTERNATIONAL INC
Health Care, Health Care Equipment
$27.55
close 7 Aug 2026
+17.43%
52-week change
$14.24B
market cap
$15.73
$30.00
52-week range
Valuation
Market cap$14.24B
P/E (TTM / 5y avg)-13.18x34.51x
Forward P/E (FY2026 / FY2027)13.47x13.36x
PEG (TTM / fwd)—16.78
P/S (TTM)1.24x
P/B2.30x
EV/EBITDA (TTM)18.89x
FCF yield (TTM)5.72%
Cash flow & dividend
FCF (TTM)$815.00M
FCF per share (TTM)$1.58
FCF margin (TTM)7.11%
Dividend yield (indicated / 5y avg)0.15%2.13%
Annualized dividend$0.0400
Payout ratio (EPS / FCF)-17.31%22.58%
Growth & quality
Revenue YoY, latest Q+5.34%
Diluted EPS YoY, latest Q+33.33%
Operating margin (TTM)-2.39%
Net margin (TTM)-9.27%
ROE (latest FY)-15.61%
Net debt / EBITDA (TTM)-1.91
Interest coverage (TTM)-0.93
Price
-63.05%-18.11%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR -0.75%10Y CAGR +1.21%
Diluted EPS
FCF per share
5Y CAGR -21.95%10Y CAGR -8.42%
Operating cash flow
5Y CAGR -14.67%10Y CAGR -7.13%
Free cash flow
5Y CAGR -22.12%10Y CAGR -9.08%
Dividends per share
5Y CAGR -5.75%10Y CAGR -8.51%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -0.22%10Y CAGR -0.72%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date28 Oct 2026
EPS estimate$0.5276
Revenue estimate$2.89B
Last reported
Date—
EPS——
Revenue——